Predictors of survival among patients diagnosed with adenocarcinoma of the esophagus and gastroesophageal junction
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Purpose Patients diagnosed with esophageal adenocarcinoma (EAC) or gastroesophageal junction adenocarcinoma (GEJAC) have poor survival. We investigated the possible influence of pre-morbid lifestyle factors on survival for these lethal cancers. Methods This study included a population-based cohort of patients with EAC (n = 362) and GEJAC (n = 421) tumors. Detailed information about demographic and lifestyle factors was obtained around the time of diagnosis, and deaths were identified using the National Death Index. Hazard ratios (HR) and 95% confidence intervals (95% CI) were calculated from Cox proportional hazards models, adjusted for age, sex, pre-treatment American Joint Committee on Cancer tumor stage, treatment and presence of comorbidities. Results Median follow-up for mortality was 6.4 years. Five-year survival rates were 27 and 33% for EAC and GEJAC, respectively. As expected, tumor and treatment characteristics were the strongest predictors of survival for both cancer sites. Among patients diagnosed with GEJAC tumors, those who were older (≥ 70 years, adjusted HR = 1.70, 95% CI 1.24-2.32) and those who reported being current smokers (adjusted HR = 1.45, 95% CI 1.02-2.06) fared worse. Other lifestyle factors putatively associated with risk of developing GEJAC including body mass index, gastroesophageal reflux symptoms, alcohol, and use of non-steroidal anti-inflammatory drugs were not associated with survival. Likewise, after adjusting for stage and treatment, no cle…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Disease stage and treatment are the strongest prognostic factors.”
From Clinical and Lifestyle-Related Prognostic Indicators among Esophageal Adenocarcinoma Patients Receiving Treatment at a Comprehensive Cancer Center (2021) · cites this paper as [12]
In the citing paper
“However, associations between body mass index (BMI) and EAC survival are conflicting, with some reports suggesting positive relationships [18,19,22], and others no association [12,23].”
From Clinical and Lifestyle-Related Prognostic Indicators among Esophageal Adenocarcinoma Patients Receiving Treatment at a Comprehensive Cancer Center (2021) · cites this paper as [12]
In the citing paper
“With respect to medications, no survival associations have been identified for pre-diagnostic aspirin/NSAID use [12,19], but post-diagnostic use of statins was linked to improved survival [27,28].”
From Clinical and Lifestyle-Related Prognostic Indicators among Esophageal Adenocarcinoma Patients Receiving Treatment at a Comprehensive Cancer Center (2021) · cites this paper as [12]
In the citing paper
“The role of lifestyle factors in relation to survival remains uncertain, with a handful of studies to date investigating associations with obesity, smoking, physical activity, diet, or medications.”
From Clinical and Lifestyle-Related Prognostic Indicators among Esophageal Adenocarcinoma Patients Receiving Treatment at a Comprehensive Cancer Center (2021) · cites this paper as [12]
In the citing paper
“but was not reported in previous EAC-specific analyses [12,18].”
From Clinical and Lifestyle-Related Prognostic Indicators among Esophageal Adenocarcinoma Patients Receiving Treatment at a Comprehensive Cancer Center (2021) · cites this paper as [12]
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742 · cited 1×
“[22], and dichotomized (none or C1 comorbidities).”
(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
Epidemiology and Pathogenesis of Esophageal Cancer
Holmes, R. S., & Vaughan, T. L. (2007) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2006.09.003 · Cited by 527 · cited 1×
“The principal causes of the increase in incidence of EAC, and to a lesser extent GEJAC, are thought to be the increasing prevalences of both gastroesophageal reflux (GER) and central obesity in white men [4–8].”
BackgroundEsophageal Adenocarcinoma Incidence: Are We Reaching the Peak?
Pohl, H., Sirovich, B., & Welch, H. G. (2010) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0012 · Cited by 421
Cook, M. B., Kamangar, F., Whiteman, D. C., Freedman, N. D., Gammon, M. D., Bernstein, L., Brown, L. M., Risch, H. A., Ye, W., Sharp, L., et al. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq289 · Cited by 316 · cited 1×
“Tobacco smoking is also an important risk factor for these cancers, whereas Helicobacter pylori infection and the frequent use of non-steroidal anti-inflammatory drugs (NSAIDs) have been associated with reduced risks, although the magnitude of their effects varies across the two tumor sites [9–11].”
BackgroundSelf-citationWhiteman, D. C., Sadeghi, S., Pandeya, N., Smithers, B. M., Gotley, D. C., Bain, C. J., Webb, P. M., Green, A. C., & Study, F. T. A. C. (2008) · Gut · doi:10.1136/gut.2007.131375 · Cited by 307 · cited 1×
“The principal causes of the increase in incidence of EAC, and to a lesser extent GEJAC, are thought to be the increasing prevalences of both gastroesophageal reflux (GER) and central obesity in white men [4–8].”
BackgroundSelf-citationTrends in oesophageal cancer incidence and mortality in Europe
Bosetti, C., Levi, F., Ferlay, J., Garavello, W., Lucchini, F., Bertuccio, P., Negri, E., & Vecchia, C. L. (2008) · International Journal of Cancer · doi:10.1002/ijc.23232 · Cited by 235 · cited 1×
“among the highest for any cancer in Western populations [1–3].”
BackgroundAbdominal Obesity and the Risk of Esophageal and Gastric Cardia Carcinomas
Corley, D. A., Kubo, A., & Zhao, W. (2008) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0748 · Cited by 211 · cited 1×
“The principal causes of the increase in incidence of EAC, and to a lesser extent GEJAC, are thought to be the increasing prevalences of both gastroesophageal reflux (GER) and central obesity in white men [4–8].”
BackgroundRubenstein, J. H., & Taylor, J. B. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04471.x · Cited by 201
Survival after surgery for oesophageal cancer: A population-based study
Rouvelas, I., Zeng, W., Lindblad, M., Viklund, P., Ye, W., & Lagergren, J. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70347-8 · Cited by 200 · cited 2×
“The strong effects of AJCC tumor stage and treatment intent on EAC survival in our cohort confirm results from earlier studies [12, 14, 16].”
BackgroundResultAlcohol Consumption and the Risks of Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus
Pandeya, N., Williams, G., Green, A. C., Webb, P. M., & Whiteman, D. C. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.12.052 · Cited by 191 · cited 2×
“Full details of the original study have been reported previously [19].”
BackgroundSelf-citationSmoking and risk of total and fatal prostate cancer in United States health professionals.
Giovannucci, E. L., Rimm, E. B., Ascherio, A., Colditz, G. A., Spiegelman, D. L., Stampfer, M. J., & Willett, W. C. (1999) · PubMed · Cited by 174
Mayne, S. T., Cartmel, B., Kirsh, V., & Goodwin, W. J. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0944 · Cited by 171 · cited 1×
“Analogous studies have reported that smoking is an independent prognostic factor for upper digestive and oral cancers [27], and we have recently reported an adverse association with ESCC survival [15].”
BackgroundDeterminants of survival following the diagnosis of esophageal adenocarcinoma (United States)
Farrow, D. C., & Vaughan, T. L. (1996) · Cancer Causes & Control · doi:10.1007/bf00052937 · Cited by 141 · cited 1×
“The strongest prognostic factors for EAC are the pathologic stage and tumor grade at diagnosis [1, 13, 14].”
BackgroundWhiteman, D. C., Parmar, P. G. K., Fahey, P. P., Moore, S., Stark, M. S., Zhao, Z., Montgomery, G. W., Green, A. C., Hayward, N. K., & Webb, P. M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.009 · Cited by 125
Self-citationOlsen, C. M., Bain, C. J., Jordan, S. J., Nagle, C. M., Green, A. C., Whiteman, D. C., Webb, P. M., & Australian Cancer Study (Ovarian Cancer) and Australian Ovarian Cancer Study Group (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0566 · Cited by 107 · cited 1×
“We derived a three-level physical activity index (low, medium, and high) based on frequency and intensity of physical activity at work and in leisure time [21].”
MethodSelf-citationPandeya, N., Williams, G. M., Sadhegi, S., Green, A. C., Webb, P. M., & Whiteman, D. C. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn091 · Cited by 105 · cited 1×
“Current smokers and ex-smokers were defined by their smoking status at 1 year prior to their diagnosis with EAC or GEJAC [20].”
MethodSelf-citationAspirin, Nonsteroidal Anti-inflammatory Drugs, and the Risks of Cancers of the Esophagus
Sadeghi, S., Bain, C. J., Pandeya, N., Webb, P. M., Green, A. C., Whiteman, D. C., & Study, F. T. A. C. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2852 · Cited by 81 · cited 1×
“Tobacco smoking is also an important risk factor for these cancers, whereas Helicobacter pylori infection and the frequent use of non-steroidal anti-inflammatory drugs (NSAIDs) have been associated with reduced risks, although the magnitude of their effects varies across the two tumor sites [9–11].”
BackgroundSelf-citationHealy, L., Ryan, A. M., Gopinath, B., Rowley, S. P., Byrne, P. J., & Reynolds, J. V. (2007) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2007.06.037 · Cited by 79 · cited 1×
“In contrast, surgical series in Ireland [26] and Houston, USA [18] found that obesity (preoperative BMI C 30) did not independently influence survival for EAC.”
ResultDemographic and lifestyle predictors of survival in patients with esophageal or gastric cancers
Trivers, K. F., de Roos, A. J., Gammon, M. D., Vaughan, T. L., RISCH, H., Olshan, A. F., SCHOENBERG, J., Mayne, S. T., Dubrow, R., Stanford, J. L., et al. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00613-5 · Cited by 77 · cited 6×
“Overall survival rates and surgical rates in our cohort were higher than national [1] and international figures [12, 16], potentially due to a ‘‘healthy cohort’’ effect (i.”
BackgroundResultInfluentialSundelöf, M., Lagergren, J., & Ye, W. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.04.002 · Cited by 75
Thrift, A. P., Nagle, C. M., Fahey, P. P., Russell, A., Smithers, B. M., Watson, D. I., & Whiteman, D. C. (2011) · International Journal of Cancer · doi:10.1002/ijc.27420 · Cited by 64 · cited 2×
“In a recent Australian study, we found that smoking and alcohol consumption were associated with poor survival for ESCC, independent of the effects of other prognostic factors [15].”
BackgroundSelf-citationPandeya, N., Webb, P. M., Sadeghi, S., Green, A. C., & Whiteman, D. C. (2010) · Gut · doi:10.1136/gut.2009.190827 · Cited by 63
Self-citationAdenocarcinoma of the oesophagus: incidence and survival rates in New South Wales, 1972–2005
Stavrou, E. P., McElroy, H. J., Baker, D. F., Smith, G., & Bishop, J. F. (2009) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2009.tb02813.x · Cited by 61
Hayashi, Y., Correa, A. M., Hofstetter, W. L., Vaporciyan, A. A., Rice, D. C., Walsh, G. L., Mehran, R. J., Lee, J. H., Bhutani, M. S., Dekovich, A. A., et al. (2010) · Cancer · doi:10.1002/cncr.25745 · Cited by 43 · cited 2×
“While one study reported a better prognosis for EAC in obese patients [12], there was no association in the other study [16], and it remains unclear whether the inverse association was confounded by tumor stage [17, 18].”
ResultSmithers, B. M., Fahey, P. P., Corish, T., Gotley, D. C., Falk, G. L., Smith, G., Kiroff, G., Clouston, A. D., Watson, D. I., & Whiteman, D. C. (2010) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2010.tb04064.x · Cited by 23 · cited 3×
“Information was collected regarding stage of disease at diagnosis (pre-treatment), tumor grade, treatment and various other clinical and pathologic prognostic variables [23].”
BackgroundMethodSelf-citationMadani, K., Zhao, R., Lim, H. J., Casson, S. M., & Casson, A. G. (2010) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2010.03.054 · Cited by 22 · cited 2×
“While one study reported a better prognosis for EAC in obese patients [12], there was no association in the other study [16], and it remains unclear whether the inverse association was confounded by tumor stage [17, 18].”
BackgroundResult
Cited by
Petrelli, F., Cortellini, A., Indini, A., Tomasello, G., Ghidini, M., Nigro, O., Salati, M., Dottorini, L., Iaculli, A., Varricchio, A., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.3520 · Cited by 530
Verbeek, R. E., Leenders, M. B., ten Kate, F. J. W., van Hillegersberg, R., Vleggaar, F. P., van Baal, J. W. P. M., van Oijen, M. G. H., & Siersema, P. D. (2014) · The American Journal of Gastroenterology · doi:10.1038/ajg.2014.156 · Cited by 152
Wu, I., Wu, C., Lu, C., Hsu, W., Wu, M., Lee, J., Chou, S., Lee, J., Chou, Y.-P., Wu, D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055834 · Cited by 48
Do smoking and alcohol behaviours influence GI cancer survival?
McMenamin, Ú. C., McCain, S., & Kunzmann, A. T. (2017) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2017.09.015 · Cited by 43
“In oesophageal adenocarcinoma patients, there was little evidence of associations with survival in three population‐ based studies [58,60,61].”
BackgroundFahey, P. P., Mallitt, K., Astell‐Burt, T., Stone, G., & Whiteman, D. C. (2015) · Cancer Causes & Control · doi:10.1007/s10552-015-0635-z · Cited by 40
Self-citation
Metadata
- Authors
- Thrift, A. P., Nagle, C. M., Fahey, P. P., Smithers, B. M., Watson, D. I., & Whiteman, D. C.
- Affiliations
- QIMR Berghofer Medical Research Institute (AU)
- Princess Alexandra Hospital (AU)
- Flinders University (AU)
- Corresponding author
- Whiteman, David C.
- ORCID
- Venue
- Cancer Causes & Control
- Published
- 2012-02-18
- Volume
- 23
- Issue
- 4
- Pages
- 555-564
- ISSN
- 0957-5243 (ISSN-L)
- 1573-7225
- OpenAlex
- W2092044294
- Cited by
- 29
- References
- 27
- Citations by year
- 2025: 1 · 2023: 1 · 2022: 2 · 2021: 2 · 2020: 4 · 2019: 4 · 2017: 2 · 2016: 2 · 2015: 4 · 2014: 3 · 2013: 3 · 2012: 1
- FWCI
- 3.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cancer Causes & Control (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Australian Research Council
- National Health and Medical Research Council
- Cancer Council NSW
- Cancer Council Queensland
- National Medical Research Council
- Topics
- Health Sciences › Medicine › Surgery › Esophageal Cancer Research and Treatment
- Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Keywords
- esophageal adenocarcinoma, gastroesophageal junction adenocarcinoma, survival predictors, lifestyle factors, smoking, age, body mass index, gastroesophageal reflux, alcohol consumption, nonsteroidal anti-inflammatory drugs, surgical treatment
- MeSH terms
- Adenocarcinoma, Aged, Esophageal Neoplasms, Esophagogastric Junction, Female, Humans, Life Style, Male, Middle Aged, Neoplasm Staging, Proportional Hazards Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.